Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
03/30/2023 | Q4 2022 | -$0.21 | -$0.32 | -0.11 | N/A | $21.31 M |
11/01/2022 | Q3 2022 | -$0.23 | -$0.28 | -0.05 | N/A | $19.57 M |
08/02/2022 | Q2 2022 | -$0.22 | -$0.26 | -0.04 | N/A | $19.31 M |
05/03/2022 | Q1 2022 | -$0.20 | -$0.21 | -0.01 | N/A | $16.66 M |
02/22/2022 | Q4 2021 | -$0.19 | -$0.27 | -0.08 | N/A | $16.17 M |
11/01/2021 | Q3 2021 | -$0.28 | -$0.23 | 0.05 | N/A | $16.35 M |
08/03/2021 | Q2 2021 | -$0.20 | -$0.11 | 0.09 | N/A | $16.61 M |
05/04/2021 | Q1 2021 | -$0.22 | -$0.17 | 0.05 | N/A | $13.86 M |
02/25/2021 | Q4 2020 | -$0.25 | -$0.13 | 0.12 | N/A | $12.86 M |
11/05/2020 | Q3 2020 | -$0.21 | -$0.11 | 0.1 | N/A | $12.83 M |
08/04/2020 | Q2 2020 | -$0.33 | -$0.30 | 0.03 | N/A | $5.64 M |
05/04/2020 | Q1 2020 | -$0.49 | -$0.49 | 0 | N/A | $10.72 M |
03/26/2020 | Q4 2019 | -$0.38 | -$0.34 | 0.04 | N/A | $11.99 M |
10/30/2019 | Q3 2019 | -$0.42 | -$0.40 | 0.02 | N/A | $11.26 M |
07/24/2019 | Q2 2019 | N/A | -$0.40 | N/A | N/A | $14.25 M |
05/02/2019 | Q1 2019 | -$0.36 | -$0.13 | 0.23 | N/A | $13.21 M |
03/18/2019 | Q4 2018 | -$0.37 | -$0.84 | -0.47 | N/A | $15.18 M |
11/08/2018 | Q3 2018 | -$0.35 | -$0.45 | -0.1 | N/A | $14.14 M |
08/08/2018 | Q2 2018 | -$0.44 | -$0.53 | -0.09 | N/A | $15.79 M |
05/03/2018 | Q1 2018 | -$0.40 | -$0.47 | -0.07 | N/A | $15.74 M |
Apollo Endosurgery, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 31st, 2023 based offlast year's report dates.
In the previous quarter, Apollo Endosurgery, Inc. (:APEN) reported $0.23 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.21 by $0.44.
The conference call for Apollo Endosurgery, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Apollo Endosurgery, Inc.'s latest earnings report can be read online.
Apollo Endosurgery, Inc. (:APEN) has a recorded annual revenue of $76.86 M.
Apollo Endosurgery, Inc. (:APEN) has a recorded net income of $-39,839,000.Apollo Endosurgery, Inc. has generated $-0.98 earnings per share over the last four quarters.
Apollo Endosurgery, Inc. (:APEN) has a price-to-earnings ratio of -10.2 and price/earnings-to-growth ratio is -0.1.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED